𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The immune response of healthy adults to a reduced dose of hepatitis B vaccine

✍ Scribed by Wolf Szmuness; Cladd E. Stevens; Edward J. Harley; Edith A. Zang; Patricia E. Taylor; Harvey J. Alter


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
592 KB
Volume
8
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Immunologic markers associated with hepatitis B virus (HBV) infection (HBsAg, anti‐HBs, HBeAg, anti‐HBe, anti‐HBc, anti‐δ) were tested by radioimmunoassay of serum from chronic hepatitis patients. The corresponding liver biopsy samples were examined for the presence of HBsAg, HBcAg, and δ antigen in the cells by direct immunofluorescence and by electron microscopy. Seventy patients were selected for the presence of both circulating HBsAg and anti‐HBc. Comparison of chronic persistent (CPH) and chronic active (CAH) hepatitis showed a significantly greater frequency of intracytoplasmic HBsAg in CPH, especially in the absence of intranuclear HBsAg, and a greater frequency of intranuclear δ antigen and/or circulating anti‐5 in CAH. The δ/anti‐δ system was almost systematically associated with serum anti‐HBe. At variance with HBeAg/anti‐HBe, δ/anti‐δ was found significantly more frequently in patients originating from Southern rather than from Northern or Central Italy. The prevalence of both these immunologic systems was related to the age of the patients.


📜 SIMILAR VOLUMES


The immune response of healthy adults to
✍ Wolf Szmuness; Cladd E. Stevens; Edward J. Harley; Edith A. Zang; Patricia E. Ta 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

## Abstract Three hundred thirty‐six medical personnel from hemodialysis centers were treated with three doses, 20 μg each, of the Merck hepatitis B vaccine (at 0, 1, and 6 months). Within 1 month after the first injection, 41% converted to anti‐HBs positivity; after the second injection the conver

The immune response of healthy nigerian
✍ E. A. Ayoola 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

The immunogenic effect of hepatitis B vaccine (H-B-vax) was evaluated in 120 seronegative healthy Nigerians. Three doses of the vaccine were given at 0, 1, and 6 months. Serial blood samples were tested I month after each vaccination for hepatitis B surface antibody (anti-HBs) and antibody to hepati

Immune responses to late booster doses o
✍ Dr. Wolfgang Jilg; Marion Schmidt; Friedrich Deinhardt 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

Nineteen healthy young adults were vaccinated with plasma-derived hepatitis B vaccine at months 0, 1, and 12, and their immune responses were compared to those of a similar group of 20 vaccinees immunized at months 0, 1, and 6. Late booster injections at 12 months produced nearly fivefold higher geo

Reduced doses of hepatitis B immune glob
✍ Tsang-Ming Ko; Fon-Jou Hsieh; Chih-Liang Yaung; Prof. Ding-Shinn Chen; Kai-Hsin 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

newborn infants of 79 hepatitis B surface antigen (HBsAg)-positive women were enrolled in a study of the efficacy of hepatitis B immune globulin (HBIG) in the prophylaxis of perinatal transmission of hepatitis B virus (HBV) infection. HBIG 0.5 ml or 0.25 ml was given to the newborn within 15 minutes